# ZNF416

## Overview
ZNF416 is a gene that encodes the zinc finger protein 416, a transcription factor involved in various cellular processes, including signal transduction and gene expression regulation. Zinc finger proteins are characterized by their zinc finger motifs, which facilitate binding to DNA and other molecules, thereby influencing transcriptional activity. ZNF416 plays a significant role in the TGF-β/Smad signaling pathway, particularly in fibroblast activation and extracellular matrix synthesis, which are critical in the context of fibrotic diseases such as pulmonary fibrosis (Melchionna2023Transcription; Cheng2022Targeted). Additionally, ZNF416 is implicated in mechanotransduction pathways, responding to changes in matrix stiffness, and potentially acts as a positive regulator of HIV-1 LTR activity (Nishitsuji2015ZNF10). The gene's involvement in these pathways underscores its potential as a therapeutic target in fibrotic conditions and other diseases.

## Clinical Significance
ZNF416 has been implicated in the pathogenesis of pulmonary fibrosis, a chronic lung disease characterized by excessive extracellular matrix deposition and fibroblast activation. Alterations in ZNF416 expression are associated with the disease's progression. The gene is identified as a mechanosensitive transcriptional regulator that responds to matrix stiffness, a key factor in fibroblast activation and fibrosis progression. Increased expression of ZNF416 is observed in fibrotic lung tissues of both mice and humans, suggesting its involvement in the disease (Cheng2022Targeted). Overexpression of ZNF416 in fibroblasts leads to increased expression of fibrotic markers such as Fibronectin and Collagen I, enhancing fibroblast proliferation and contractility. Conversely, knockdown of ZNF416 results in decreased fibroblast proliferation and reduced expression of these markers (Cheng2022Targeted).

Therapeutically, targeting ZNF416 with siRNA-loaded liposomes has shown promise in experimental models. This approach significantly reversed established pulmonary fibrosis in mice, particularly when combined with a TGF-β1 receptor inhibitor, which further attenuated fibrosis (Cheng2022Targeted). These findings highlight the potential clinical significance of ZNF416 as a molecular target for intervention in fibrotic diseases.

## Interactions
ZNF416 is involved in interactions with the TGF-β/Smad signaling pathway, which is crucial for fibroblast activation. It does not alter Smad2/3 mRNA levels but affects their phosphorylation. Overexpression of ZNF416 increases the phosphorylation and nuclear translocation of Smad2/3, while ZNF416 knockdown inhibits these processes. Co-immunostaining and co-immunoprecipitation assays have demonstrated that ZNF416 colocalizes and interacts with phosphorylated Smad2/3 in fibroblasts treated with TGF-β1, suggesting a significant role in modulating this signaling pathway (Cheng2022Targeted).

ZNF416 is also described as being downstream to mechanotransduction, supporting fibroblast contractile activation, proliferation, and ECM synthesis. This indicates that ZNF416 may interact with components of the mechanotransduction pathway, although specific protein interactions are not detailed (Melchionna2023Transcription).

In the context of HIV-1 LTR activity, ZNF416 is suggested to potentially act as a positive regulator, promoting LTR-driven transcription. However, specific interactions with other proteins or nucleic acids in this context are not detailed (Nishitsuji2015ZNF10).


## References


[1. (Cheng2022Targeted) Demin Cheng, Ziwei Li, Yue Wang, Haojie Xiong, Wenqing Sun, Siyun Zhou, Yi Liu, and Chunhui Ni. Targeted delivery of znf416 sirna-loaded liposomes attenuates experimental pulmonary fibrosis. Journal of Translational Medicine, November 2022. URL: http://dx.doi.org/10.1186/s12967-022-03740-w, doi:10.1186/s12967-022-03740-w. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12967-022-03740-w)

[2. (Melchionna2023Transcription) Roberta Melchionna, Paola Trono, Anna Di Carlo, Francesca Di Modugno, and Paola Nisticò. Transcription factors in fibroblast plasticity and caf heterogeneity. Journal of Experimental &amp; Clinical Cancer Research, December 2023. URL: http://dx.doi.org/10.1186/s13046-023-02934-4, doi:10.1186/s13046-023-02934-4. This article has 4 citations.](https://doi.org/10.1186/s13046-023-02934-4)

[3. (Nishitsuji2015ZNF10) Hironori Nishitsuji, Leila Sawada, Ryuichi Sugiyama, and Hiroshi Takaku. Znf10 inhibits hiv‐1 ltr activity through interaction with nf‐κb and sp1 binding motifs. FEBS Letters, 589(15):2019–2025, June 2015. URL: http://dx.doi.org/10.1016/j.febslet.2015.06.013, doi:10.1016/j.febslet.2015.06.013. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.febslet.2015.06.013)